The sodium-potassium ATPase (Na<sup>+</sup>/K<sup>+</sup>-ATPase), particularly its catalytic α-subunit, is overexpressed in A549 non-small cell lung cancer (NSCLC) and has thus emerged as a potential therapeutic target. Here, XK is linked to non-small cell lung carcinoma.